Fig. 3
From: Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers
AA-PET and MRI findings in a case of differential diagnosis between TML and breast cancer brain metastasis. 71 years old female patient previously treated for breast cancer who underwent ceMRI that showed the presence of a left frontal lesion hyperintense at T2 sequences (Panel a) and hypointense at T1 sequences (Panel b). AA-PET/CT with 18F-Dopa showed a low tracer uptake supporting the hypothesis of TML. ceMRI performed three months after therapy administration showed the reduction in both lesion dimension (Panel d) and enhancement (Panel e)